News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

C.R. Bard Buys FlowCardia, Inc. For $80 Million


5/21/2010 8:17:51 AM

P.E. Hub -- C. R. Bard Inc. (NYSE: BCR) has acquired FlowCardia Inc., a Sunnyvale, Calif.-based developer of endovascular devices for coronary and peripheral chronic total occlusion (CTO) recanalization, according to VentureWire. The deal is worth around $80 million.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES